The National Institutes of Health (NIH), through the National Institute on Aging (NIA), has issued a funding opportunity titled "Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)." This program aims to encourage early-stage and diverse researchers to undertake innovative studies focused on Alzheimer's disease (AD) and associated dementias (ADRD). Grants of up to $100,000 per year for two years are available to support projects addressing various topics related to AD/ADRD, including prevention, diagnosis, treatment, and care. The initiative specifically targets individuals who have not previously competed for significant NIH awards in AD/ADRD research and aims to generate pilot data that can lead to larger funding applications. The application process opens on January 16, 2025, with subsequent deadlines following a structured review cycle. Eligible applicants include academic institutions, nonprofits, and government entities, with a strong encouragement for applications from underrepresented groups. The program underscores the NIH's commitment to enhancing research capabilities in AD/ADRD and addressing workforce diversity in biomedical research.